Compare ARK Genomic Revolution ETF (ARKG) vs Nasdaq100 ETF (QQQ) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Nasdaq100 ETF — how do they compare? ARK Genomic Revolution ETF trades at $41.21, while Nasdaq100 ETF trades at $718.94. Which is the better fit depends on your goals.
| ARKG | QQQ | |
|---|---|---|
Sector | Sector/Thematic | — |
52-Week High | $43.57 | $746.16 |
52-Week Low | $23.09 | $553.88 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
QQQ trades at $725.54, up 0.32% with a bullish technical signal from moving averages. Support lies at $718 and resistance at $727. The ETF faces new competition from BlackRock's IQQ but maintains strong Nasdaq-100 exposure. Recent news highlights its role in growth portfolios and hedging strategies using SQQQ.
Outlook remains mixed with 50% analyst buy ratings. Key risks include market volatility and competitive ETF launches. Upside potential hinges on tech sector performance, while downside protection strategies are gaining attention among investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Nasdaq100 ETF
The ETF is designed to track the performance of the securities and the stocks in the NASDAQ-100 Index. To maintain the composition and weightings, the advisor adjusts the ETF from time to time to conform to periodic changes in the index target.
Read more on QQQ →
